“The unique fusion of individual innovative technologies will provide a novel diagnostic tool leading to a better understanding of the underlying pathophysiology of rare anaemia.”

Lars Kaestner, Coordinator of CoMMiTMenT

News archive

  • Dec
    European Commission (EC) co-funded project e-ENERCA successfully ended on 30th September 2016
    In 2002, the EC co-funded project ENERCA, which stands for European Network for Rare and Congenital Anaemias, started with its first phase (European Network for Rare Congenital Anaemias) dedicated to congenital anaemias. It continued with a second phase (European Network for Rare and Congenital Anaemias) incorporating, in addition, acquired rare anaemias, while the third phase of ENERCA focused...
  • Nov
    OpenIOLabs at Innovate 2016, Manchester
    CoMMiTMenT consortium member OpenIOLabs won one of the only 100, much sought-after places available at Innovate UK, which took place on 2 and 3 November, 2016 in Manchester, UK. This exhibition presented a mixture of start-ups, scale-ups and export-ready businesses at the cutting-edge of their field, delivering originality to the UK and beyond. OpenIOLabs was proud to exhibit and demonstrate...
  • Nov
    CoMMiTMenT beneficiary ORX at BioJapan 2016
    CoMMiTMenT beneficiary ORX was invited to exhibit at the Scandinavian booth at the 18th BioJapan conference in Yokohama, Japan, which took place from 12 to 14 October, 2016. ORX was proud to follow the invitation, which was an excellent opportunity to present their latest developments to an international audience in many face-to-face meetings and also distribute the CoMMiTMenT project flyer to...
  • Oct
    CoMMiTMenT Consortium holds 5th Progress Meeting
    Coordinator Lars Kaestner was pleased to welcome the CoMMiTMenT consortium to the 5th Progress Meeting, which took place on 6th October 2016. This time, the CoMMiTMenT consortium decided to hold their progress meeting via web conference, the platform for which was kindly provided by software partner Arivis AG. This rather unusual way of arranging a progress meeting was chosen in order to allow...
  • May
    CoMMiTMenT Partner OptoRobotix ApS presents research results on light-driven micro-tool equipped with a syringe function in Nature Publishing Group
    OptoRobotix ApS, consortium member in the EC-funded FP7 project CoMMiTMent and H2020 ITN RELEVANCE, and the PPO research group at DTU Fotonik made the top story in the Danish online tech-magazine Ingeniøren with their research results on a light-driven micro-tool equipped with a syringe function. Their corresponding paper, accepted for publication in Light: Science and Application by Nature...
  • Mar
    CoMMiTMenT Coordinator Dr Lars Kaestner gives invited presentation at the German Pharm-Tox Summit
    From 29th February to 3rd March 2016, the ‘German Pharm-Tox Summit’ took place at the Free University in Berlin. This prestigious event brings together basic scientists and clinical pharmacologists every year, thus enabling intensive knowledge transfer. Within the ‘Advanced Courses in Pharmacology’, Dr Lars Kaestner, CoMMiTMenT coordinator of Saarland University, gave an invited presentation on...
  • Dec
    Epigem makes progress on CoMMiTMenT
    Epigem, a high-tech British micro engineering company, has made significant progress on the CoMMiTMenT (Combined Molecular Microscopy for Therapy and Personalised Medication in Rare Anaemia Treatments) project including mimicking functions of the spleen. The project’s clinical partners are now testing devices created by Epigem, which are based on their microfluidics abilities. These work by...